Age Has No Significant Impact on Overall Survival and on Treatment Tolerability in Relapsed Stage IV Cutaneous Malignant Melanoma Patients Receiving Cisplatin, Gemcitabine, and Treosulfan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Age Has No Significant Impact on Overall Survival and on Treatment Tolerability in Relapsed Stage IV Cutaneous Malignant Melanoma Patients Receiving Cisplatin, Gemcitabine, and Treosulfan

Published:2011-02 Issue:1 Volume:34 Page:2-5
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Atzpodien Jens,Terfloth Kerstin,Fluck Michael,Reitz Martina

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference13 articles.

1. A case for geriatric oncology.;Repetto;Lancet Oncol,2002

2. Aging and the hemopoietic system.;Pinto;Crit Rev in Oncol/Hematol,2003

3. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.;Serrone;J Exp Clin Cancer Res,2000

4. Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients.;Corrie;Br J Cancer,2005

5. Chemosensitivity testing malignant melanoma.;Ugurel;Recent Results Cancer Res,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP